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Abstract DNA methylation is the epigenetic modification, which introduces 5mC as fifth base onto DNA. As for the
distribution of 5mCs, it is well known that they distribute themselves in a non-random fashion in genomic DNA so that
methylation pattern is characterized by the presence of methylated cytosines on the bulk of DNA while the unmethylated
ones are mainly located within particular regions termed CpG islands. These regions represent about 1% of genomic DNA
and are generally found in the promoter region of housekeeping genes. Their unmethylated state, which is an essential
condition for the correct expression of correlated genes, is paradoxical if one considers that these regions are termed CpG
islands because they are particularly rich in this dinucleotide, which is the best substrate for enzymes involved in DNA
methylation. Anomalous insertion of methyl groups in these regions generally leads to the lack of transcription of
correlated genes. An interesting scientific problem is to clarify the mechanism(s) whereby CpG islands, which remain
protected from methylation in normal cells, are susceptible to methylation in tumor cells. How the CpG moieties in CpG
islands become vulnerable or resistant to the action of DNA methyltransferases and can thus lose or maintain their
characteristic pattern of methylation is still an open question. Our aim is to gather some mechanisms regarding this
intriguing enigma, which, despite all energy spent, still remains an unresolved puzzle. J. Cell. Biochem. 94: 257–265,
2005.  2004 Wiley-Liss, Inc.
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DNA METHYLATION MACHINERY
DNA methylation [for reviews see Costello
and Plass, 2001; Bird, 2002; Zlatanova et al.,
2004] is the post-synthetic modification which,
by transferring a methyl group from S-adeno-
sylmetionine to carbon-5 of cytosine ring,
introduces 5mC as new base on DNA. Enzymes
involved in this reaction are DNA methyl-
transferases and their preferential target for
methylation are cytosines located in CpG dinu-
cleotides. The mCpG dinucleotides are distrib-
uted in a non-random fashion in genomic DNA
so that methylation pattern is characterized
by the presence of methylated cytosines on the
bulk of DNA, while the unmethylated ones
are mainly located within particular regions
termed CpG islands. Specific DNA methylation
pattern results from the combination of main-
tenance and de novo methylation and demethy-
lation processes. Maintenance methylation,
which occurs within aminute or two after repli-
cation, recognizes and modifies hemimethy-
lated sites generated during DNA replication
thus preserving the tissue-specific methylation
pattern. DNA methyltransferase 1 (Dnmt1) is
considered primarily responsible for mainte-
nance methylation due to its preference for
hemimethylated DNA, its maximum level of ex-
pression being in S cell-cycle phase [Szyf et al.,
1991] andnot the least because of its association
with proliferating cell nuclear antigen (PCNA)
during DNA replication at DNA replication foci
[Chuang et al., 1997]. Dnmt3a and Dnmt3b are
considered responsible for the de novo methyla-
tion process, which explains how the pattern of
methylation can be changed by introducing new
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methyl groups onto DNA at sites in which
neither strand was previously methylated.
These enzymes play an important role during
early stages of embryonic development when a
bimodal pattern ofmethylation is defined [Kafri
et al., 1992]. It is important to say that it is too
simplistic to consider that only these enzymes
are involved in DNA methylation as for most of
them there are several isoforms and newDnmts
have been identified [for review see Robertson,
2002]. A great deal of research is being carried
out to establish their roles. The original dis-
tribution of roles mentioned above for the main
Dnmts may have to be reconsidered in light of
the fact that some of them have been seen
cooperating in maintaining DNA methylation
and gene silencing in human cancer cells during
DNA replication [for review see El-Osta, 2003].
The thermodynamic problem, concerning the
removal of methyl groups from cytosine makes
the understanding of DNA demethylation
mechanism somewhat complicated. A DNA
demethylase activity, capable of catalyzing
replacement of the methyl group with a hydro-
gen derived from water and of releasing the
methyl group in the form of methanol, has been
proposed as well as the alternative possibility of
the removal of 5mC or 5mCpG dinucleotide by
glycosylase activity and their substitution with
the unmethylated base or dinucleotide. What-
ever the enzymatic mechanism(s) may be, DNA
demethylation is an active process in cells and
plays a role not only in the definition of the
methylation pattern in early stages of develop-
ment but also in the passage towards patholo-
gical events as tumorigenesis [for reviews see
Cedar and Verdine, 1999; Bird, 2003].
Histone modifications, DNA methylation,
and proteins able to bind methylated DNA play
a dynamic role in determining chromatin
structure suitable for gene expression or silen-
cing. At present, much information is available
as to how several epigenetic modifications work
together in determining regions of chromatin
that have to be more or less suitable for trans-
cription [for review see Jaenisch and Bird,
2003]. An unresolved problem is the timing
with which the various epigenetic events occur
in establishing gene expression. On this subject
at least two scenarios can be suggested. One
foresees DNA methylation as the first event, as
it was observed that histone deacetylase can
reach chromatin through its association with
proteins able to recognize and bind methylated
DNA [Jones et al., 1998; Nan et al., 1998]. The
second scenario considers DNA methylation to
be the final stabilizing moment, which occurs
only after epigenetic events associated with
histones (i.e., K9H3 methylation) have already
shut down gene expression [for review see Bird,
2001].
DISTRIBUTION OF mCpG AND CpG
DINUCLEOTIDES ON GENOMIC DNA
The frequency with which CpG dinucleotides
are found on genome is much lower than ex-
pected, except for CpG island regions where
their number is nearer to the expected one. This
happened during evolution due to the presence
of spontaneous deaminase activity in nuclei [for
review see Jones and Baylin, 2002]. This enzy-
matic reaction transforms methylated cytosine
into thymine while the unmethylated cytosine
is transformed into uracil. Subsequent control
and repair mechanisms recognize uracil as an
extraneous base on DNA and thus substitute it,
while this substitution does not happen where
thymine is concerned as it is a common base on
DNA.
Going back to CpG islands being enriched in
CpG dinucleotides, the explanation lies in the
non methylation of their normal state, which
preserves their regions from deamination-
dependent mutations.
Summarizing some characteristics of CpG
islands [Antequera and Bird, 1993; Antequera
and Bird, 1994; Antequera, 2003] there are
about 30,000 generally located in the 50 promo-
ter region of housekeeping genes, sometimes
overlapping the coding region to variable ex-
tents (usually the first exon). Although their
sequence is enriched in CpG dinucleotides,
which are the best substrates for DNA methyl-
transferase, the CpG islands are unmethylated.
There is evidence that the transcription of genes
associated with them is active when these re-
gions are in unmethylated state, while it is
inhibited when these regions undergo methyla-
tion [for reviews see Jones and Baylin, 2002;
Robertson, 2002]. It is to note that CpG islands
have recently been found in several tissue-
specific and imprinted genes within the genes
themselves without their methylation blocking
gene expression [for review see Jones, 1999].
Along DNA other discrete regions, enriched
in CpG dinucleotides, must be considered. They
are repetitive elements termed B elements [for
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review see Turker 2002] in mice and Alu
elements in humans [Takai and Jones, 2002].
Analysis of sequence of human chromosomes 21
and 22 has led to the definition of more strin-
gent parameters, which allow the distinguish-
ing of CpG islands and Alu sequences [Takai
and Jones, 2002]. The new parameters for
definition of CpG islands are fixed in this way:
minimum size 0.5 kbp, CþG content 55%
and observed CpG/expected CpG 0.65. The
important difference between CpG islands and
Alu repeats lies in the fact that the latter are a
good substrate for the DNA methylation that
occurs in these regions that are generally
methylated. B and Alu sequences are defined
cis-acting methylation centers both as sus-
pected of signalling de novo DNA methylation
and as—in absence of a boundary—theymay be
able to spreadmethylation to the adjacent DNA
regions.
A strong association is shown between CpG
islands and Alu repeats. A detailed analysis of
the sequence of human chromosomes 21 and
22 showed that 54.4% of CpG islands occur
between Alu regions and the number of CpGs
that are found in 50 regions of genes, is about the
same as the number of Alu-associated CpGs
[Takai and Jones, 2002].
JIGSAW OF UNMETHYLATED STATE
OF CpG ISLANDS
Concerning the regulation of DNA methyla-
tion process, two unresolved questions are:
a) to clarify the mechanism by which CpG
islands are protected from methylation
during replication and in chromatin;
b) to understand how CpG islands, located in
the promoter regions of tumor suppressor
genes, become methylated during tumor-
igenesis while they are unmethylated in
normal cells.
There has been a lot of research to discover
the mechanism that normally keeps CpG
islands unmethylated, some of which has tried
to pinpoint cis-acting sequences able to conduct
such an important mechanism. As CpG island
sequences have been seen to be methylatable in
in vitro experiments the hypothesis that they
are intrinsically unmethylatable has fallen
through [Bestor et al., 1992].
Attention of many researchers has been
diverted to consensus binding sites for tran-
scription factor Sp1 [Brandeis et al., 1994;
Macleod et al., 1994; Mummaneni et al., 1998].
The mouse aprt housekeeping gene — whose
CpG island includes the promoter, the first and
second exons, and the first intron — has been
chosen for the study of this mechanism as Sp1
consensus sites are present in its promoter
region. Their connection to the mechanism that
keeps the CpG islands unmethylated is being
researchedwith interest as these Sp1 sites often
occupy a strategic position both in themouse B1
[for review see Turker, 2002] and in the human
Alu repetitive elements that often flank CpG
islands [Takai and Jones, 2002]. B1 and Alu
sequences—because of their high methylation
level—are considered methylation centers and
Sp1 sites in these patterns are seen as bound-
aries able to stop the spreading of methylation
fromB1andAlu elements to unmethylatedCpG
islands (Fig. 1).
The diffusion ofmethylation frommethylated
CpG dinucleotides toward the adjacent
unmethylated ones has previously been amply
shown [for review see Lindsay and Adams,
1996], but without explaining how CpG islands
are protected from the spreading of methyla-
tion. As concerns the expression of mouse aprt
gene, it has been shown that among the Sp1
consensus sites, sites three and four are re-
quired for gene transcription while site two is
the specific one in the blocking of methylation
spreading and is reinforced in this role by sites
three and four [Mummaneni et al., 1998]. Their
silencing is a gradual process in differentiated
cells [Yates et al., 2003]. If it is the boundary
caused by Sp1, which isolates the islands from a
general state ofmethylation, it can be presumed
that in tumorigenesis this mechanism is, in
some way, lost (Fig. 1).
However, data in literature are not unan-
imous as while some experiments show that the
gene-correlated CpG island ismethylated when
Sp1 binding sites, in correspondence with gene,
are disrupted by direct mutagenesis [Brandeis
et al.,1994; Macleod et al., 1994; Mummaneni
et al., 1998], no anomalous methylation of CpG
islands is found in mice in which Sp1 is not
expressed following homozygous deletion
[Marin et al., 1997]. Anyway this mechanism
cannot be considered universal as Sp1 consen-
sus sites are not always present in promoter
regions of housekeeping genes. It is reasonable
to think that some other transcription factor(s),
through their ties with active promoters
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containing CpG islands, can act as trans-acting
elements able to protect the unmethylated state
of these DNA regions. Experiments, carried out
on T24 bladder carcinoma cell line, in which the
remethylation kinetics was examined for p16
gene after it had been demethylated by treat-
ment with 5-aza 20-deoxycytidine, have shown
that the timing of remethylation varied, being
longer for promoter region than for coding
regions of gene, i.e. exon 2. This could be due
to the presence of transcription factor(s) on
promoter region capable of impeding Dnmt1
from entering DNA [Bender et al., 1999].
An important point in determining variation
of methylation patterns is the nuclear level of
Dnmt1 as it has been often seen to be high in
tumor cells [Baylin et al., 2001]. Thus anom-
alous increased level of the enzyme could be
involved in determining aberrant introduction
of newmethyl groups onto DNA. Housekeeping
gene promoters are hypermethylated, with the
silencing of correlated genes, inhumancell lines
expressing 50-fold increased level of Dnmt1
(HMT) [Vertino et al., 1996] and further re-
search, performed on the same cells, has shown
that not all loci containing CpG rich regions
are equally affected by methylation in cells
overexpressing Dnmt1 but about 70% of them
were resistant to de novo methylation and only
a few of them (3.8%) were methylation-prone
[Feltus et al., 2003]. Recently, it has been shown
that RNA interference (RNAi)-mediated silen-
cing of Dnmt1 leads to promoter demethylation
and re-expression of some tumor suppressor
genes in several cancer cells [Robert et al., 2003;
Suzuki et al., 2004]. This confirms the impor-
tant role played by Dnmt1 in tumorigenesis
although additional data have shown that
CpG island hypermethylation is maintained in
human cancer cells after homozygous deletion
[Rhee et al., 2000] or RNAi-mediated depletion
of Dnmt1 [Ting et al., 2004].
As, not all tumor cells inwhich there is hyper-
methylation of tumor suppressor genes show an
Fig. 1. Alu repeats and CpG islands are physically and func-
tionally correlated on genomic DNA: a role for Sp1 elements. In
the scheme CpG island is juxtaposed to multiple Alu elements,
which have been proposed as ‘‘de novo methylation centers.’’
Sp1 sites, located upstream and downstream of transcription start
in the island, play a role in preventing methylation. Cluster of Sp1
elements is suggested as boundary region capable of protecting
CpG island from the spreading of methylation arising from Alu
elements. Grey and red lollipops represent non-methylated and
methylated CpGs, respectively.
260 Caiafa and Zampieri
overexpression ofDnmt1 [Eads et al., 1999], and
as the expression of Dnmt1 is cell-cycle depen-
dent [Szyf et al., 1991], attention has been
diverted to the idea that the expression of
Dnmt1 can occur in an anomalous cell-cycle
phase—i.e., in G1/early S phase—when CpG
rich regions and active genes replicate [Delgado
et al., 1998]. It has been observed that remethy-
lation process can also occur in cells blocked in
G1 [Bender et al., 1999].
In this scenario the competition existing
between p21 and Dnmt1 for the same binding
domain on PCNA [Chuang et al., 1997] may
play an important role. PCNA is the protein to
which Dnmt1 binds when, immediately follow-
ing replication, the maintenance methylation
intervenes to guarantee that methylation pat-
tern of the parent strand is conserved on the
newly synthesized one. In early S phase, when
CpG island regions replicate [Delgado et al.,
1998], the level of Dnmt1 is too low to compete
with p21 for the binding site on PCNA and so
replication occurs without subsequent methy-
lation. It has been suggested that, as yet, an
unidentified biological event, able to induce
Dnmt1 expression in early S phase, could make
the binding to PCNA easier thus allowing
the methylation of early replicating genes in
tumorigenesis [Baylin, 1997].Moreover,Dnmt1
seems to be a cofactor capable of regulating
negative expression of p21 through a direct or
indirect link with Sp1 [Milutinovic et al., 2004].
Thus, an anomalous overexpression of Dnmt1
in the early S phase could further facilitate the
formation of PCNA–Dnmt1 complex.
The biological event able to induce Dnmt1
overexpression in the early S phase could be
poly(ADP-ribosyl)ationas ithas been found that
competitive inhibition of PARPs leads to intro-
duction of anomalous methyl groups onto DNA
[Zardo et al., 1997, 1999; Zardo and Caiafa,
1998; de Capoa et al., 1999], hyperexpression of
Dnmt1 in G1/early S phase and increase of the
amount of Dnmt1 that co-immunoprecipitates
with PCNA in this phase [Zardo et al., 2002],
(Fig. 2, Panel A). How poly(ADP-ribosyl)ation
is involved in the control of Dnmt1 expres-
sion is still unclear and it is to define whether
it is involved in the regulation of Dnmt1 gene
or in the regulation of another gene or protein
involved in the regulation of Dnmt1 expression.
A second mechanism has been suggested for
PARP1 in the control of DNA methylation.
In this hypothesis PARP1 in its poly(ADP-
ribosyl)ated isoformmakes Dnmt1 catalytically
inactive (Fig. 2, panel B). To understand this
suggested mechanism it must be said that
modified isoform of PARP1 presents in its
central domain many (about 28) ADP-ribose
chains that can even be up to 200 units in length
and be branched [D’Amours et al., 1999]. Mod-
ified PARP1 can be seen as a molecular adaptor
characterized by a clear negative charge onto
which chromatin proteins can be attracted and
hosted. Several proteins show a greater affinity
for these polymers than for DNA so that ADP-
ribose polymers compete withDNA for the bond
with them.This non-covalent link,which is very
strong [Panzeter et al., 1992], is not specifically
guided by an attraction between charges, but
proteins showing high affinity for polymers
have anaminoacid domain,which is responsible
for the interaction with ADP-ribose polymers
[Pleschke et al., 2000]. Dnmt1 has two possible
consensus aminoacid domains for binding with
ADP-ribose polymers [Reale et al., 2004].
dsDNA 30 times more concentrated does not
remove link between Dnmt1 and ADP-ribose
polymers and in vitro experiments have shown
how ADP-ribose polymers present on modified
PARP1 almost completely inhibit the catalytic
activity of Dnmt1, while unmodified PARP1 is
not able to inhibit the enzyme. These data,
added to the fact that the two proteins co-
immunoprecipitate in vivo and that PARP1 is
in its modified form in this complex, suggest
that modified PARP1 trapping Dnmt1 through
ADP-ribose polymers, is responsible for the
catalytic inactivation of the enzyme in chroma-
tin [Reale et al., 2004]. Through thismechanism
the non-methylated state of CpG islands could
be protected and a functional anomaly in the
poly(ADP-ribosyl)ation process could therefore
be responsible for new aberrant methylation
(Fig. 2, panel B).
Thus, inhibition of PARP activity could allow
new methyl groups to be inserted onto DNA
both during replication and in chromatin:
during replication because inhibition of PARP
activity induces Dnmt1 overexpression in G1/S
phase and increases the formation of the
active complex PCNA-Dnmt1 in this anomalous
phase [Zardo et al., 2002] and in chromatin
because unmodified PARP1 is unable to inhibit
Dnmt1 [Reale et al., 2004].
The existence of a protein, which linksDnmt1
inhibits its catalytic activity, thus preventing
the introduction of new methyl groups onto
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DNA has been suggested. This role is played by
Rb [Pradhan andKim, 2002], a protein involved
in cell-cycle control and therefore having an
important role as tumor suppressor gene. It has
been shown that Rb links through its pockets B
and C the regulatory domain of Dnmt1 and that
following this association the bond existing
between Dnmt1 and DNA is destabilized. Over-
expression of Rb leads to DNA hypomethyla-
tion. All this suggests that this mechanism
plays a role in the hypermethylation of onco-
suppressor genes in tumors where often Rb is
absent or mutated [Hanahan and Weinberg,
2000].
The outcome that ORIs map within or
immediately adjacent to CpG islands has been
seenasamechanismprobably involved inmain-
taining the unmethylated state of CpG islands.
Fig. 2. Inhibition of PARP activity induces DNA hypermethyla-
tion. Panel A reports the scheme proposed to explain DNA
hypermethylation dependent on PARP inhibition during DNA
replication. a: In normal cells, modified PARP1 plays a role in
controlling the expression of Dnmt1 in the appropriate cell-cycle
phase, and thus the level of Dnmt1-PCNA active complex is low
in G1/S phase. b: Inhibition of PARP activity induces over-
expression of Dnmt1 in G1/S phase, causing anomalously high
level of the active Dnmt1-PCNA complex in this phase. Panel B
reports the scheme proposed to explain DNA hypermethylation
dependent on PARP inhibition in chromatin. a: In normal cells,
ADPR-polymers, present on PARP1, link in uncovalent way
Dnmt1. Affinity of Dnmt1 for ADPR-polymers is so high that they
compete with dsDNA 30 times more concentrated for the
binding with the enzyme and the presence of ADPR-polymers
almost completely inhibits the Dnmt1 activity in vitro. b: In-
hibition of poly(ADP-ribosyl)ation frees Dnmt1 from its tie with
PARP1 and in absence of ADPR-polymers Dnmt1 activity is re-
stored. Thus, following inhibition of poly(ADP-ribosyl)ation, the
two mechanisms could cooperate in inducing anomalous DNA
hypermethylation.
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Analysis of very short DNA fragments
(<1.5 kbp), which are formed at the beginning
of S phase, allowed the observation that their
sequence is similar to that of unmethylatedCpG
island regions. Replication time of CpG islands
is about 2–2.5 h while the bulk of DNA needs
more time to replicate. Thus origins of replica-
tion colocalize frequently with CpG islands so
that the great number of proteic factors involv-
ed in these processes could be enough to make
access difficult to Dnmt1 that, as mentioned
above, is less expressed in early S-phase.
Experiments performed on human X-linked
hypoxantine phosphoribosyltransferase gene
(HPRT) have shown that colocalization of CpG
islands and ORIs is dependent on the methyla-
tion state of CpG island. In fact the CpG island,
which is methylated in the inactive allele,
replicates in late S phase [Schmidt andMignon,
1990]. Thus, unmethylated CpG island regions
should beparticularly suitable for startingDNA
replication because of their uncondensed chro-
matin structure [Tazi and Bird, 1990] and this
colocalization has been suggested as a mechan-
ism by which CpG islands are protected from
methylation during replication [Antequera and
Bird, 1999], (Fig. 3).
Finally, there are proteins that target Dnmts
on specific DNA regions and mediate transcrip-
tional silencing [for reviews see Robertson,
2002; El-Osta, 2003].
At present much information is available but
not enough to allow the elaboration of a final
model(s) explaining how CpG islands are pro-
tected from methylation. In spite of the great
effort put into solving this scientific problem,
still much has to be done to provide definite
proof, which solves this fascinating puzzle.
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